Literature DB >> 11172992

Study on the pathophysiology of experimental Burkholderia pseudomallei infection in mice.

Y P Gauthier1, R M Hagen, G S Brochier, H Neubauer, W D Splettstoesser, E J Finke, D R Vidal.   

Abstract

Burkholderia pseudomallei is the etiological agent of melioidosis, a potentially fatal disease occurring in man and animals. The aim of this study was to investigate the pathophysiological course of experimental melioidosis, and to identify the target organs, in an animal model. For this purpose SWISS mice were infected intraperitoneally with the virulent strain B. pseudomallei 6068. The bacterial load of various organs was quantified daily by bacteriological analysis and by an enzyme-linked immunosorbent assay (ELISA) based on a monoclonal antibody specific to B. pseudomallei exopolysaccharide (EPS). Electron microscopic investigation of the spleen was performed to locate the bacteria at the cellular level. In this model of acute melioidosis, B. pseudomallei had a marked organ tropism for liver and spleen, and showed evidence of in vivo growth with a bacterial burden of 1.6x10(9) colony forming units (CFU) per gram of spleen 5 days after infection with 200 CFU. The highest bacterial loads were detected in the spleen at all time points, in a range from 2x10(6) to 2x10(9) CFU g(-1). They were still 50-80 times greater than the load of the liver at the time of peak burden. Other investigated organs such as lungs, kidneys, and bone marrow were 10(2)-10(4)-fold less infected than the spleen, with loads ranging from 3x10(2) to 3x10(6) CFU g(-1). The heart and the brain were sites of a delayed infection, with counts in a range from 10(3) to 10(7) times lower than bacterial counts in the spleen. The EPS-specific ELISA proved to be highly sensitive, particularly at the level of those tissues in which colony counting on agar revealed low contamination. In the blood, EPS was detected at concentrations corresponding to bacterial loads ranging from 8x10(3) to 6x10(4) CFU ml(-1). Electron microscopic examination of the spleen revealed figures of phagocytosis, and the presence of large numbers of intact bacteria, which occurred either as single cells or densely packed into vacuoles. Sparse figures suggesting bacterial replication were also observed. In addition, some bacteria could be seen in vacuoles that seemed to have lost their membrane. These observations provide a basis for further investigations on the pathogenesis of the disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11172992     DOI: 10.1111/j.1574-695X.2001.tb01550.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  10 in total

Review 1.  Antibodies for biodefense.

Authors:  Jeffrey W Froude; Bradley Stiles; Thibaut Pelat; Philippe Thullier
Journal:  MAbs       Date:  2011-11-01       Impact factor: 5.857

2.  Strategies for PCR based detection of Burkholderia pseudomallei DNA in paraffin wax embedded tissues.

Authors:  R M Hagen; Y P Gauthier; L D Sprague; D R Vidal; G Zysk; E-J Finke; H Neubauer
Journal:  Mol Pathol       Date:  2002-12

3.  Immunostimulatory CpG oligodeoxynucleotide confers protection in a murine model of infection with Burkholderia pseudomallei.

Authors:  Surasakdi Wongratanacheewin; Wannapa Kespichayawattana; Pakamas Intachote; Sathit Pichyangkul; Rasana W Sermswan; Arthur M Krieg; Stitaya Sirisinha
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

4.  Experimental acute respiratory Burkholderia pseudomallei infection in BALB/c mice.

Authors:  Mark S Lever; Michelle Nelson; Anthony J Stagg; Richard J Beedham; Andrew J H Simpson
Journal:  Int J Exp Pathol       Date:  2009-02       Impact factor: 1.925

5.  Comparative genomics and an insect model rapidly identify novel virulence genes of Burkholderia mallei.

Authors:  Mark A Schell; Lyla Lipscomb; David DeShazer
Journal:  J Bacteriol       Date:  2008-01-25       Impact factor: 3.490

6.  Murine pulmonary infection and inflammation induced by inhalation of Burkholderia pseudomallei.

Authors:  T Eoin West; Nicolle D Myers; H Denny Liggitt; Shawn J Skerrett
Journal:  Int J Exp Pathol       Date:  2012-12       Impact factor: 1.925

7.  Oropharyngeal aspiration of Burkholderia mallei and Burkholderia pseudomallei in BALB/c mice.

Authors:  Kevin L Schully; Matthew G Bell; Jerrold M Ward; Andrea M Keane-Myers
Journal:  PLoS One       Date:  2014-12-11       Impact factor: 3.240

8.  Comparison of Five Commercial Nucleic Acid Extraction Kits for the PCR-based Detection of Burkholderia Pseudomallei DNA in Formalin-Fixed, Paraffin-Embedded Tissues.

Authors:  Sonja Obersteller; Heinrich Neubauer; Ralf Matthias Hagen; Hagen Frickmann
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2016-09-29

9.  Laser Scanning Confocal Microscopy Was Used to Validate the Presence of Burkholderia Pseudomallei or B. Mallei in Formalin-Fixed Paraffin Embedded Tissues.

Authors:  Kei Amemiya; Xiankun Zeng; Jeremy J Bearss; Christopher K Cote; Carl Soffler; Robert C Bernhards; Jennifer L Dankmeyer; Wilson J Ribot; Sylvia R Trevino; Susan L Welkos; Patricia L Worsham; David M Waag
Journal:  Trop Med Infect Dis       Date:  2020-04-29

10.  Efficacy of post exposure administration of doxycycline in a murine model of inhalational melioidosis.

Authors:  H Carl Gelhaus; Michael S Anderson; David A Fisher; Michael T Flavin; Ze-Qi Xu; Daniel C Sanford
Journal:  Sci Rep       Date:  2013-01-28       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.